Cross-sectional studies reported that hepatitis B core gene mutations are associated with active liver disease and responsiveness to interferon therapy. In view of the heterogeneity in published sequences, it is not possible to tell whether the differences in sequences observed were true mutations t
677 HEPATITIS B VIRUS SPLICING VARIANTS EMERGE AND DOMINATE IN THE IMMUNE CLEARANCE PHASE OF CHRONIC HEPATITIS B
β Scribed by H. Yotsuyanagi; N. Yamada; H. Miyoshi; T. Tsutsumi; H. Fujie; Y. Shintani; K. Moriya; C. Okuse; K. Yasuda; M. Suzuki; F. Itoh; S. Iino; K. Koike
- Book ID
- 117376603
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 57 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To assess the significance of cell-mediated immunity, T cells were derived from the peripheral blood and liver tissue of hepatitis B virus (HBV)-infected patients and controls. The analysis of the 3H-thymidine-uptake in response to a panel of recombinant HBV antigens revealed that peripheral blood m
Based on virological and biochemical parameters patients with chronic hepatitis B virus (HBV) are divided into distinct clinical phases: the immunetolerance phase, the immune-clearance phase, and the inactive carrier state. Unclear is whether these phases have characteristic intrahepatic immune resp